|Batroxobin for prevention of restenosis in diabetic patients after infrapopliteal arterial angioplasty: a small randomized pilot trial.|
|PMID: 20831989 Owner: NLM Status: MEDLINE|
|BACKGROUND: We designed a small randomized clinical trial to prospectively test the hypothesis that batroxobin is more effective than aspirin alone to prevent restenosis in patients with diabetes undergoing angioplasty of infrapopliteal arteries.
METHODS: After a successful angioplasty, a total of 52 diabetic patients with symptomatic infrapopliteal obstructions were randomized to either the treated group (n = 26) or the control group (n = 26). Patients in the treated group received 5 IU batroxobin through an intravenous drip once every alternate day, for a total of six doses. The primary end point was restenosis and reocclusion, which was documented by magnetic resonance angiography or duplex scanning at 12-month follow-up. The clinical symptoms relief and ankle-brachial index (ABI) were compared before and after the procedure, and during follow-up. Kaplan-Meier curves were constructed to evaluate restenosis or reocclusion-free, limb salvage, and amputation-free rates.
RESULTS: Restenosis and reocclusion occurred in 22.0% and 34.5% lesions in the treated and the control group, respectively (p = 0.0307). Statistical differences were observed between the ABI before the angioplasty procedure(p < 0.05) and the ABI at the 12-month follow-up (p = 0.0094) of the two groups. Clinical symptoms improvement and tissue healing occurred in 23 and 19 patients in the batroxobin group and the control group, respectively (p = 0.0544). Twelve months after angioplasty, Kaplan-Meier analysis showed that the restenosis and reocclusion-free rate was 74.0% and 54.8%, the limb salvage rate was 96.2% and 92.3%, and the amputation-free rate was 84.6% and 84.6%, in the treated and control group, respectively.
CONCLUSION: This pilot trial revealed that batroxobin usage was effective in preventing restenosis and reocclusion after infrapopliteal arterial angioplasty, and it might provide better clinical symptoms relief; however, it did not report preferable limb salvage or amputation-free rates.
|Jue Wang; Yue-Qi Zhu; Fang Liu; Ming-Hua Li; Jun-Gong Zhao; Hua-Qiao Tan; Jian-Bo Wang; Ying-Sheng Cheng; Pei-Lei Zhang|
Related Documents :
|15286319 - Long-term cardiovascular morbidity, mortality, and reintervention after endovascular tr...
12894369 - Primary utilization of stents in angioplasty of superficial femoral artery.
8866079 - Clinical and vascular laboratory determinants for outcome after infrainguinal atherectomy.
25295719 - Effects of postoperative analgesia with the combination of tramadol and lornoxicam on s...
15071779 - Infrapopliteal angioplasty.
1835929 - Angioplasty of the terminal aorta: follow-up of 20 patients treated by pta or pta with ...
9657489 - Neuropsychological results of craniopharyngioma surgery in adults: a prospective study.
3998419 - Combined reduction osteotomy for triphalangeal thumb.
24512909 - Combination therapy with infliximab and azathioprine is superior to monotherapy with ei...
|Type: Journal Article; Randomized Controlled Trial|
|Title: Annals of vascular surgery Volume: 24 ISSN: 1615-5947 ISO Abbreviation: Ann Vasc Surg Publication Date: 2010 Oct|
|Created Date: 2010-09-13 Completed Date: 2011-01-11 Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 8703941 Medline TA: Ann Vasc Surg Country: United States|
|Languages: eng Pagination: 876-84 Citation Subset: IM|
|Copyright © 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.|
|Department of Radiology, Sixth Affiliated People's Hospital, Medical School of Shanghai Jiao Tong University, Shanghai, People's Republic of China.|
|APA/MLA Format Download EndNote Download BibTex|
Angioplasty* / adverse effects
Ankle Brachial Index
Arterial Occlusive Diseases / diagnosis, therapy*
Aspirin / therapeutic use
Batroxobin / administration & dosage, therapeutic use*
Diabetic Angiopathies / diagnosis, therapy*
Fibrinolytic Agents / administration & dosage, therapeutic use*
Magnetic Resonance Angiography
Popliteal Artery* / pathology, ultrasonography
Recurrence / prevention & control
Severity of Illness Index
Ultrasonography, Doppler, Duplex
|0/Fibrinolytic Agents; 50-78-2/Aspirin; EC 3.4.21.-/Batroxobin|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Long-term outcome of endovascular popliteal artery aneurysm repair.
Next Document: Fate of popliteal artery aneurysms after exclusion and bypass.